n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Innocenti, A; Nencetti, S; Nuti, E; Orlandini, E; Rossello, A; Scozzafava, A; Supuran, CT | 1 |
1 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Multiple Myeloma
Article | Year |
---|---|
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.
Topics: Animals; Carbonic Anhydrase I; Carbonic Anhydrase II; Cytosol; Enzyme Inhibitors; Humans; Hydroxamic Acids; Isoenzymes; Matrix Metalloproteinase Inhibitors; Mice; Molecular Structure; Multiple Myeloma; Structure-Activity Relationship; Sulfonic Acids; Tumor Cells, Cultured | 2007 |